Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00693290|
Recruitment Status : Unknown
Verified June 2008 by University of Ulster.
Recruitment status was: Not yet recruiting
First Posted : June 9, 2008
Last Update Posted : June 9, 2008
Study hypothesis The overall aim of this study is to compare two bowel preparations that are used prior to a colonoscopy procedure.
The principal research questions are:
- Does the use of a low residue diet increase patient concordance to the bowel preparation instructions?
- Does the use of a low residue diet decrease the adequacy of assessment of the mucosa?
- Does the use of a low residue diet increase the willingness of patients to undertake repeated examination as is required for disease follow−up?
- Does body weight affect perceived tolerability of either group?
|Condition or disease||Intervention/treatment|
|Colorectal Cancer||Other: low residue diet|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Official Title:||Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy|
|Study Start Date :||June 2008|
|Estimated Primary Completion Date :||December 2008|
|Estimated Study Completion Date :||December 2008|
Active Comparator: 1
Fleet plus low residue diet sheet.
Other: low residue diet
Fleet (usual preparation) plus diet sheet for low residue diet
Other Name: Sodium Phosphate
No Intervention: 2
No intervention, usual care, Fleet plus liquid only diet
- Clarity of the mucosa evaluated by the Ottawa Scale. [ Time Frame: At endoscopy screening ]
- Concordance with the bowel preparation. [ Time Frame: Prior to the endoscopy ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00693290
|Contact: Daphne Garrett||287-134-5171 ext firstname.lastname@example.org|
|Contact: Siobhan McCann, PhDemail@example.com|
|Western Health and Social Care Trust||Not yet recruiting|
|Londonderry, Northern Ireland, United Kingdom, BT476SB|
|Contact: Daphne Garrett 287-134-5171 ext 3761 firstname.lastname@example.org|
|Principal Investigator:||Daphne Garrett||Western Health and Social Care Trust|